- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
Over the past three decades, historic progress has transformed HIV from a deadly disease to a chronic condition. Critical milestones have been reached towards universal access: more than 17 million people globally are receiving HIV treatment, and the world is on track to eliminate mother to child transmission of HIV.
Still, more than 2 million people are newly infected with HIV annually. Last year alone 1.1 million people needlessly lost their lives and HIV remains one of the leading causes of death among children under five years old, adolescents and women of reproductive age. Since the beginning of the epidemic, more than 70 million people have died due to AIDS. Despite the extraordinary progress, HIV remains a serious challenge for global health and development goals.
This report is the outcome of a comparative analysis of seven national investment cases from the region, and highlights key findings and recommendations for further action. The findings from this report and the Regional Expert Consultation on Developing Evidence-Based National HIV Investment Cases and Sustainability Plans held in December 2015 are expected to contribute to the knowledge base on how ESCAP Member States have developed national investment cases (NICs), and identify examples of best practice. The analysis was based primarily on a desk review of the investment cases of Bangladesh, Indonesia, Myanmar, Nepal (Investment Plan), the Philippines, Thailand and Viet Nam, with additional input from in-country respondents and from the Regional Expert Consultation.
Keywords: HIV, epidemic, spending, investment, cases, advocacy
In the context of discussions on health spending targets, this paper analyses not only how much countries spend on health, but how they performance in terms of universal health coverage (UHC) relative to that spending. The paper highlights the limited use of spending targets to inform country policy dialogue and decision making.
Keywords: universal health coverage (UHC), health spending, expenditure targets
Smart, effective health investments through the Global Fund have saved 17 million lives, expanding opportunities and achieving greater social justice for families and communities worldwide. Scientific advances, innovative ideas and private sector expertise are unlocking improvements in disease prevention, treatment and care.
The global commitment to ending the AIDS epidemic represents an unparalleled opportunity to end one of the most devastating modern-day health challenges. Over the past three decades, historic progress has transformed the AIDS response. More than 18 million people globally are receiving life-saving HIV treatment, and the world is on track to eliminate mother-to-child transmission of HIV. However, more than 2 million people are newly infected with HIV annually and, in 2015, more than a million people died from HIV-related causes. Strategic partnerships such as that of UNAIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) are vital if we are to Fast-Track the AIDS response to end AIDS as a public health threat by 2030.
The Economic and Fiscal Update is a “Supplement to the 2016-2017 Budget Address”. It provides the general outlook for Fiji‟s economic and financial performance and outlines Government‟s fiscal strategy for the medium term. The information contained in the Economic and Fiscal Update is as of June 2016.
Countries in the WHO Western Pacific Region have made considerable progress in preventing and controlling the HIV epidemic. Governments have scaled up access to life-saving antiretroviral therapy, and new HIV infections in the Region have decreased by 20% between 2000 and 2015. Despite this progress, many challenges remain on the path to ending the HIV epidemic.
This report examines the resource challenges that confront the AIDS response in Asia and the Pacific. It proposes a set of interventions that will help overcome them and steer the region towards ending its AIDS epidemic.
The report summarizes the analysis done by an independent, expert advisory panel on AIDS funding in Asia and the Pacific, convened jointly by UNAIDS and the World Bank in August 2013. The Expert Panel was tasked with reviewing the prospects for ending the region’s AIDS epidemic in the context of changing global economy and external funding environment.
Keywords: HIV, AIDS, prevention, testing, treatment, funding, global fund
The HIV epidemic amongst men who have sex with men (MSM) in Bangkok is substantial. The population size of MSM in Bangkok is 120,000-250,000, with approximately one-third (33.5 percent) considered high-risk, characterized by their young age, multiple partnerships, frequent unprotected anal intercourse, and sexual activities around MSM hotspots. In metropolitan Bangkok, HIV prevalence among MSM reportedly increased from 21 percent to 28 percent between 2000 and 2012. The Thai Working Group of Estimation and Projection (2013) projected an estimate of 39,000 new HIV infections would occur in Thailand during 2012-2016, based on the AIDS Epidemic Model (AEM).
While the response to the region’s HIV epidemic has chalked up impressive gains in HIV prevention and treatment, too many people continue to fall through the gaps in existing services.
The ADB Cooperation Fund for Fighting HIV/AIDS in Asia and the Pacific benefitted from a $19.2 million grant from the Government of Sweden with the goal of assisting ADB’s developing member countries meet their commitment to Millennium Development Goal 6, target 6A: to have halted by 2015 and begun to reverse the spread of HIV. The objective of the fund was to support these countries to develop a comprehensive AIDS response; enable them to partner with ADB in areas that play to the bank’s strategic value and advantages; and particularly to benefit subregions, countries and communities that are most vulnerable to HIV.
This report summarizes the experiences and lessons learned of the Cooperation Fund.
Download summary sheets